April 26, 2022
by Andrii Buvailo
Interview
Quantum computing is a growing trend due to recent major advances in hardware making this technology a practically feasible thing. …
April 20, 2022
by Andrii Buvailo
Interview
There is a new generation of tech-savvy drug discovery companies, applying the power of artificial intelligence (AI) to accelerate and …
April 18, 2022
by Andrii Buvailo
Interview
There is a new wave of innovation that is sweeping through pharmaceutical drug discovery: targeted protein degradation (TPD). TPD is …
April 14, 2022
by Andrii Buvailo
Interview
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
March 22, 2022
by Andrii Buvailo
Interview
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Feb. 22, 2022
by Andrii Buvailo
Interview
Researchers are looking to capitalize on the abundance of new types of data and higher resolution data to drive innovation. …
Sept. 9, 2021
by Andrii Buvailo
Interview
High-Resolution Ion Mobility Mass Spectrometry (HRIM-MS) has emerged as a promising new separations technique in the biopharmaceutical and clinical market. …
March 28, 2021
by Andrii Buvailo
Interview
The team at Insilico Medicine has recently reported that they achieved a major milestone for their comprehensive artificial intelligence (AI)-based …
Feb. 11, 2021
by Andrii Buvailo
Interview
In its 2020 Tech Trends report, CB Insights has profiled the 14 tech trends that it considers deserving attention in …
Jan. 22, 2021
by Andrii Buvailo
Interview
With several decades of advances in quantum theory and simultaneous progress in a number of software and hardware fields, we …
Sept. 28, 2020
by Andrii Buvailo
Interview
Recently, COVAXX announced it would soon enter human trials as the company is focused on rapidly developing a Multitope Peptide-based …
Sept. 25, 2020
by Andrii Buvailo
Interview
Founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker, Paradigm4 is not just any data analytics company …